Genentech’s Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer
Genentech, a unit of Roche Holdings AG (OTC:RHHBY), announced that the Phase 3 IMbrave050 study met its primary endpoint of recurrence-free survival…
Johnson & Johnson’s HIV Vaccine Regimen Does Not Prevent Infection, Phase 3 Study Shows
The Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) announced the results of an independent, scheduled data review of the Phase 3 Mosaico study of the investigational HIV vaccine regimen.
Bayer Bolsters Its Position In Digital Medical Imaging With Acquisition Of UK-Based Firm
Bayer AG (OTC:BAYRY) (OTC:BAYZF) has agreed to acquire Blackford Analysis Ltd, a British developer of artificial intelligence (AI) systems offering clinical…
Another Tech Giant Prepares For Major Layoffs, This Time 11,000 Jobs Will Be Cut: Report
Tech giant Microsoft Inc (NASDAQ: MSFT) is preparing to lay off thousands of employees, according to multiple reports.
FDA Approves Abbott’s Next-Gen Navitor TAVI System For Aortic Stenosis
The FDA has approved Abbott Laboratories (NYSE:ABT) latest-generation transcatheter aortic valve implantation (TAVI) system, Navitor, to treat people with severe…
AbbVie, Eli Lilly Leave UK’s Voluntary Medicines Pricing Agreement Over Increasing Prices
The Association of the British Pharmaceutical Industry (ABPI) said pharmaceutical giants AbbVie Inc (NYSE:ABBV) and Eli Lilly And Co (NYSE:LLY) have withdrawn from Britain’s…
Amid Sluggish Sales In China, Alibaba Rolls Out ‘Buy Now Pay Later’ Option
Splitit Payments Ltd (OTCQX: SPTTY) and Alipay have
Barron’s Top Weekend Stock Picks: Amazon, Tesla, Disney And Why Big Tech May Be In For A Major Comeback
Benzinga reviews this weekend's top stories covered by Barron's, here are the articles investors need to read.